U.S. FDA authorizes Pfizer's COVID-19 booster for 12- to 15-year-olds
- marketing56741
- Jan 3, 2022
- 1 min read
On Monday January 3rd, the U.S. Food and Drug Administration authorized the use of a third dose of the Pfizer COVID-19 vaccine for children ages 12 to 15.
sd